Clearance Summary
CELL-DYN RAPID-LYSE AND HEMOGLOBLIN received FDA 510(k) clearance under submission number K881242, sponsored by Abbott Diagnostics. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 1988-04-21.
- Submission: K881242
- Applicant / Sponsor: Abbott Diagnostics
- Clearance pathway: Traditional
- Review panel: Hematology
- Device class: Class II
- Regulation citation: 21 CFR 864.7500
- Decision date: 1988-04-21
Classification & Regulation
This clearance is catalogued under FDA product code GJZ and 21 CFR 864.7500, within the Hematology review panel as a Class II device.